NASDAQ:GNMK GenMark Diagnostics (GNMK) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free GNMK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$24.04▼$24.0450-Day Range$23.89▼$24.0452-Week Range$8.42▼$24.25VolumeN/AAverage Volume2.70 million shsMarket Capitalization$1.76 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get GenMark Diagnostics alerts: Email Address Ad True Market InsidersExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About GenMark Diagnostics Stock (NASDAQ:GNMK)GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the developing and commercializing molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company also offers Blood Culture Identification Gram-Positive and Negative panel, Blood Culture Identification Fungal Pathogen panel, and ePlex Gastrointestinal Pathogen Panel. In addition, it provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. Further, the company offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, thrombophilia risk test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test and eSensor SARS-CoV-2 Test. GenMark Diagnostics, Inc. sells its products through direct sales and technically specialized service organization in the United States, Europe, and internationally. The company was incorporated in 2010 and is headquartered in Carlsbad, California.Read More Ad True Market InsidersExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 GNMK Stock News HeadlinesMarch 15, 2024 | finance.yahoo.comQuest Diagnostics Incorporated (DGX)July 8, 2023 | nbcnews.comYouTube star Grace Helbig shares breast cancer diagnosisJune 6, 2023 | usatoday.comStudy finds brain 'signature' for chronic pain, which could improve diagnosis, treatmentJune 2, 2023 | lse.co.ukGenmark Diagnos Share ChatMay 28, 2023 | usatoday.comWhen autism isn't diagnosed until adulthood: 'It takes a mental crisis to get diagnosed'April 29, 2023 | nypost.comDoctor who helped broaden autism spectrum ‘very sorry’ for over-diagnosisApril 27, 2023 | benzinga.comWith 11.1% CAGR, Molecular Diagnostics Market to Surpass US$ 37.19 Bn by 2028 - Global Analysis by TMRFebruary 23, 2023 | nypost.comBruce Willis’ family reveals ‘cruel’ dementia diagnosisFebruary 18, 2023 | cbsnews.comWhat is frontotemporal dementia? Bruce Willis' diagnosis, explainedFebruary 18, 2023 | cbsnews.comCelebrities react to Bruce Willis' frontotemporal dementia diagnosisJanuary 26, 2023 | finance.yahoo.comHepatitis B and C diagnostics market size to increase by USD 2,055.79 million; North America to account for 47% of market growth - TechnavioJanuary 17, 2023 | nypost.comChristina Applegate says she’s nervous about first awards show since MS diagnosisJanuary 10, 2023 | finance.yahoo.comGravity Diagnostics Appoints Karen Hargett as Chief People OfficerDecember 31, 2022 | finance.yahoo.comInfectious Disease Diagnostics Global Market Report 2022: Increasing Availability and Affordability of Rapid Diagnostic Kits Presents OpportunitiesOctober 30, 2022 | finance.yahoo.comMolecular Diagnostics Market is Booming and Expected to Reach USD 37.19 Billion to 2028, notes TMR StudyOctober 16, 2022 | newsweek.comGena Tew Reveals Whether She's Able To Have Children After AIDS DiagnosisOctober 5, 2022 | finance.yahoo.comBoston Heart Diagnostics Launches LipoMap™: One of the Most Comprehensive Assessments of Lipid Metabolism AvailableJuly 30, 2022 | thestreet.comGenMark Diagnostics, Inc. NewsMay 6, 2022 | benzinga.comSpecific Diagnostics announces that Nathan Clark, former GenMark Sales Leader, joins Specific Diagnostics as Strategic Account Director, US EastSee More Headlines Receive GNMK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GenMark Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/25/2021Today6/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:GNMK CUSIPN/A CIK1487371 Webwww.genmarkdx.com Phone760-448-4300FaxN/AEmployees618Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,350,000.00 Net Margins-16.95% Pretax MarginN/A Return on Equity-39.36% Return on Assets-13.02% Debt Debt-to-Equity Ratio0.75 Current Ratio4.33 Quick Ratio3.84 Sales & Book Value Annual Sales$88.02 million Price / Sales19.96 Cash FlowN/A Price / Cash FlowN/A Book Value$0.21 per share Price / Book114.48Miscellaneous Outstanding Shares73,086,000Free FloatN/AMarket Cap$1.76 billion OptionableOptionable Beta3.02 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Scott Mendel (Age 54)Pres & CEO Comp: $506.61kMr. John Frederick Ek (Age 45)Chief Financial Officer Comp: $423.71kMr. Michael Gleeson (Age 46)Sr. VP of Corp. Accounts Comp: $395.17kMr. Abe ChohanSr. VP of OperationsMr. Eric Stier (Age 45)Sr. VP, Gen. Counsel & Sec. Mr. Scott O'Brien (Age 45)Sr. VP of Global Marketing & International Sales Ms. Hollis Winkler (Age 46)VP of HR Mr. Tyler Jensen (Age 52)Sr. VP of Engineering & Product Technical Support More ExecutivesKey CompetitorsLuminexNASDAQ:LMNXT2 BiosystemsNASDAQ:TTOOGlaukosNYSE:GKOSInspire Medical SystemsNYSE:INSPMerit Medical SystemsNASDAQ:MMSIView All Competitors GNMK Stock Analysis - Frequently Asked Questions How were GenMark Diagnostics' earnings last quarter? GenMark Diagnostics, Inc. (NASDAQ:GNMK) announced its quarterly earnings results on Thursday, February, 25th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.04. The medical equipment provider earned $50.08 million during the quarter, compared to analyst estimates of $50 million. GenMark Diagnostics had a negative net margin of 16.95% and a negative trailing twelve-month return on equity of 39.36%. What is Scott Mendel's approval rating as GenMark Diagnostics' CEO? 4 employees have rated GenMark Diagnostics Chief Executive Officer Scott Mendel on Glassdoor.com. Scott Mendel has an approval rating of 75% among the company's employees. What other stocks do shareholders of GenMark Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other GenMark Diagnostics investors own include Matinas BioPharma (MTNB), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Inovio Pharmaceuticals (INO), Dynavax Technologies (DVAX), Miragen Therapeutics (MGEN), Aeterna Zentaris (AEZS), Bionano Genomics (BNGO), CBL & Associates Properties (CBL) and Hallador Energy (HNRG). This page (NASDAQ:GNMK) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GenMark Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GenMark Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.